Search

Your search keyword '"Sui, Guangchao"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Sui, Guangchao" Remove constraint Author: "Sui, Guangchao" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
48 results on '"Sui, Guangchao"'

Search Results

1. Data from β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

2. Data from β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

3. Supplementary Figures 1-5 from β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

4. Supplementary Figures 1-5 from β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

5. Data from IRP2 Regulates Breast Tumor Growth

6. Data from Suppression of Tak1 Promotes Prostate Tumorigenesis

8. Data from Suppression of Tak1 Promotes Prostate Tumorigenesis

13. Supplementary Figure 2 from Suppression of Tak1 Promotes Prostate Tumorigenesis

14. Supplementary Figure 1 from Suppression of Tak1 Promotes Prostate Tumorigenesis

18. Supplementary Methods, Legends for Tables 1-2, Figures 1-4 from Suppression of Tak1 Promotes Prostate Tumorigenesis

19. Supplementary Table 2 from Suppression of Tak1 Promotes Prostate Tumorigenesis

20. Supplementary Figure 4 from Suppression of Tak1 Promotes Prostate Tumorigenesis

25. Supplementary Figure 4 from Suppression of Tak1 Promotes Prostate Tumorigenesis

26. Supplementary Methods, Legends for Tables 1-2, Figures 1-4 from Suppression of Tak1 Promotes Prostate Tumorigenesis

28. Supplementary Figure 3 from Suppression of Tak1 Promotes Prostate Tumorigenesis

30. Supplementary Table 2 from Suppression of Tak1 Promotes Prostate Tumorigenesis

31. Supplementary Table 1 from Suppression of Tak1 Promotes Prostate Tumorigenesis

35. Data from IRP2 Regulates Breast Tumor Growth

38. β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

39. CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools

40. IRP2 Regulates Breast Tumor Growth

44. Suppression of Tak1 Promotes Prostate Tumorigenesis

Catalog

Books, media, physical & digital resources